Cytokinetics financials
WebMar 24, 2024 · CYTOKINETICS, INCORPORATED : Forcasts, revenue, earnings, analysts expectations, ratios for CYTOKINETICS, INCORPORATED Stock CYTK US23282W6057 WebCYTK Finanicals Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert After Hours Last Updated: Mar 8, 2024 7:23 p.m. EST Delayed...
Cytokinetics financials
Did you know?
WebFeb 24, 2024 · Cytokinetics has received committed capital of $70 million, and will receive up to $330 million from Ji Xing in additional milestone payments plus tiered royalties on the net sales of omecamtiv mecarbil in Greater China, subject to certain reductions. 2024 … WebFeb 6, 2014 · Financial Guidance 2014. Cytokinetics also announced its financial guidance for 2014. The company anticipates cash revenue will be in the range of $19 to $21 million, cash R&D expenses will be in ...
WebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the fourth quarter and full year 2024. Net loss for the fourth quarter was $137.4 million or $1.45 per share and the net loss for the year 2024 was $389.0 million or $4.33 per share. WebAug 4, 2024 · SOUTH SAN FRANCISCO, Calif., Aug. 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the second quarter of 2024. Net loss for the second...
WebApr 5, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media. Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, …
WebMar 31, 2024 · April 10, 2024. Cytokinetics to Participate in the 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif. , April 10, 2024 (GLOBE NEWSWIRE) -- …
WebApr 6, 2024 · CYTK Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. portable hemodialysis machineWebNov 3, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the third quarter of 2024. Net loss for the third quarter was $76.1 million, or $0.95 per share, compared to net loss for the third quarter of 2024 of $3.2 million, or $0.05 per share. portable hemodynamic monitorWebFeb 17, 2024 · Cytokinetics Financials Summary financials Revenue ( FY, 2024) $94.6M Net income ( FY, 2024) ($389.0M) Cash ( FY, 2024) $65.6M EBIT ( FY, 2024) ($324.2M) … irs abhishriWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% … irs aberdeen south dakotaWebCytokinetics Stock Is Surging. Heart-Drug Results Are Exciting Investors. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-4.25 Market Cap $3.46 B Shares Outstanding 95.16 … portable hen house plansWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … portable hendheld bluetooth printerWebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … irs able